These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3024797

  • 1. Immunization of Canadian Armed Forces personnel with live types 4 and 7 adenovirus vaccines.
    Chaloner-Larsson G, Contreras G, Furesz J, Boucher DW, Krepps D, Humphreys GR, Mohanna SM.
    Can J Public Health; 1986; 77(5):367-70. PubMed ID: 3024797
    [No Abstract] [Full Text] [Related]

  • 2. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.
    Top FH, Buescher EL, Bancroft WH, Russell PK.
    J Infect Dis; 1971 Aug; 124(2):155-60. PubMed ID: 4330998
    [No Abstract] [Full Text] [Related]

  • 3. Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types.
    Gooch WM, Mogabgab WJ.
    Arch Environ Health; 1972 Dec; 25(6):388-94. PubMed ID: 4343867
    [No Abstract] [Full Text] [Related]

  • 4. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.
    Top FH, Grossman RA, Bartelloni PJ, Segal HE, Dudding BA, Russell PK, Buescher EL.
    J Infect Dis; 1971 Aug; 124(2):148-54. PubMed ID: 4330997
    [No Abstract] [Full Text] [Related]

  • 5. Recent experiences with live adenovirus vaccines in navy recruits.
    Rosenbaum MJ, Edwards EA, Hoeffler DF CAPT.
    Mil Med; 1975 Apr; 140(4):251-7. PubMed ID: 167324
    [No Abstract] [Full Text] [Related]

  • 6. Live and inactivated adenovirus vaccines. Clinical evaluation of efficacy in prevention of acute respiratory disease.
    Griffin JP, Greenberg BH.
    Arch Intern Med; 1970 Jun; 125(6):981-6. PubMed ID: 4378136
    [No Abstract] [Full Text] [Related]

  • 7. Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits.
    Pierce WE, Rosenbaum MJ, Edwards EA, Peckinpaugh RO, Jackson GG.
    Am J Epidemiol; 1968 Jan; 87(1):237-46. PubMed ID: 4295428
    [No Abstract] [Full Text] [Related]

  • 8. Emergence of adenovirus type 14 in US military recruits--a new challenge.
    Binn LN, Sanchez JL, Gaydos JC.
    J Infect Dis; 2007 Nov 15; 196(10):1436-7. PubMed ID: 18008220
    [No Abstract] [Full Text] [Related]

  • 9. A tale of two vaccines.
    Katz SL.
    Clin Infect Dis; 2000 Sep 15; 31(3):671-2. PubMed ID: 11017813
    [No Abstract] [Full Text] [Related]

  • 10. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.
    Top FH, Dudding BA, Russell PK, Buescher EL.
    Am J Epidemiol; 1971 Aug 15; 94(2):142-6. PubMed ID: 4327997
    [No Abstract] [Full Text] [Related]

  • 11. Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits.
    Pierce WE, Peckinpaugh RO, Frazier WE, Griffin JP, Greenberg BH, Jackson GG.
    Antimicrob Agents Chemother (Bethesda); 1965 Aug 15; 5():55-8. PubMed ID: 4286921
    [No Abstract] [Full Text] [Related]

  • 12. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J, Abarbanel MF, Oei KG.
    J Hyg (Lond); 1968 Dec 15; 66(4):499-511. PubMed ID: 4303951
    [No Abstract] [Full Text] [Related]

  • 13. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group.
    Gray GC, Goswami PR, Malasig MD, Hawksworth AW, Trump DH, Ryan MA, Schnurr DP.
    Clin Infect Dis; 2000 Sep 15; 31(3):663-70. PubMed ID: 11017812
    [Abstract] [Full Text] [Related]

  • 14. Surveillance snapshot: adenovirus among U.S. military recruit trainees.
    Hawksworth A.
    MSMR; 2012 Mar 15; 19(3):5. PubMed ID: 22452713
    [No Abstract] [Full Text] [Related]

  • 15. How contagious are common respiratory tract infections?
    Hartzell JD, Oster CN, Gaydos JC.
    N Engl J Med; 2003 Jul 03; 349(1):95. PubMed ID: 12840101
    [No Abstract] [Full Text] [Related]

  • 16. Adenovirus vaccines in the U.S. military.
    Gaydos CA, Gaydos JC.
    Mil Med; 1995 Jun 03; 160(6):300-4. PubMed ID: 7659229
    [Abstract] [Full Text] [Related]

  • 17. Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012.
    Hoke CH, Hawksworth A, Snyder CE.
    MSMR; 2012 Mar 03; 19(3):2-4. PubMed ID: 22452712
    [Abstract] [Full Text] [Related]

  • 18. Current use and future directions of adenovirus vaccine.
    Gurwith MJ, Horwith GS, Impellizzeri CA, Davis AR, Lubeck MD, Hung PP.
    Semin Respir Infect; 1989 Dec 03; 4(4):299-303. PubMed ID: 2560582
    [Abstract] [Full Text] [Related]

  • 19. Adenovirus vaccines in military recruit populations: a cost-benefit analysis.
    Collis PB, Dudding BA, Winter PE, Russell PK, Buescher EL.
    J Infect Dis; 1973 Dec 03; 128(6):745-52. PubMed ID: 4358121
    [No Abstract] [Full Text] [Related]

  • 20. Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982.
    Meiklejohn G.
    J Infect Dis; 1983 Nov 03; 148(5):775-84. PubMed ID: 6313818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.